CONFLICT OF INTEREST STATEMENT
T.T. received honoraria from Celltrion, Chugai, Daiichi Sankyo, Eisai, and Eli Lilly. M.I., T.K., T.O., T.M., D.S., and K.A. have no conflict of interest. T.A. received honoraria from AstraZeneca, Chugai, Eisai, Eli Lilly, Kyowa Kirin, and Pfizer. N.M received honoraria from AstraZeneca, Chugai, Eisai, Eli Lilly, and Pfizer; and research funds from AstraZeneca, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Kyowa Kirin, Mochida, MSD, Nihon Kayaku, Novartis, Pfizer, and Sanofi. N.N. received honoraria from AstraZeneca, Chugai, Daiichi Sankyo, Eisai, Eli Lilly Japan, Nippon Kayaku, and Pfizer; and research funds from Chugai, Daiichi Sankyo, Eli Lilly Japan, Mochida, Nippon Kayaku, and Pfizer; and research grants from Chugai and Eisai. Y.Y., M.W., and M.T. are Mochida Pharmaceutical Co., Ltd employees.